Avac Event

HIV Drug Therapy Glasgow 2018

The program is of interest to clinical investigators from across the globe to review current research and to discuss its implications for HIV management strategies. In addition to looking at these treatment issues, the Congress is moving into areas, such as prevention, with time in the program focused on pre-exposure prophylaxis (PrEP) and issues across Europe and beyond.

The important role of people living with HIV in treatment decisions and self-management continues to feature, and we look forward to a number of perspective from the community.

For more information, visit hivglasgow.org, or download a flyer.

Avac Event

New WHO Guidelines for HIV Testing Services Webinar

A critical first step in achieving the 90-90-90 targets proposed by UNAIDS is ensuring that 90 percent of all people living with HIV will know their HIV status by 2020. This is an ambitious goal, as currently only half of people living with HIV know their status. The recently released WHO HIV testing guidelines address and respond to this reality. The WHO’s Dr. Rachel Baggaley, unpacked the HIV testing guidelines and highlighted the need-to-know specifics of the new guidelines.

Listen to the recording here.

View the slides here.

Avac Event

WHO Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV

WHO recently issued an “Early Release Guideline” on when to start antiretroviral therapy and on pre-exposure prophylaxis (PrEP) for HIV. This document recommends 1) initiation of ART in adults living with HIV, regardless of CD4 cell count, and 2) offer of PrEP as a prevention option to all people at substantial risk of acquiring HIV. (The release is “early” relative to a comprehensive update of its consolidated ARV guidelines, slated to come out at the end of the year.) If implemented, these sweeping recommendations have the potential to change the world by simplifying ART for people living with HIV and revolutionizing prevention for people at risk.

In this webinar, Meg Doherty and Bob Grant from the Department of HIV/AIDS at WHO, spoke about the guideline and took questions. Links to the full presentation, slides and audio are below.

And for more background, Meg Doherty gave a presentation at IAS 2015 in Vancouver. Download the slides or view the presentation.

Avac Event

EATG 2015 webinar 2: Treatment for all: prevention and community implications

Following the recent announcement of new guidelines by WHO, this webinar looked at the implications of treatment for all for HIV prevention programmes.

Speakers included Professor Jens Lundgren, one of the principal investigators of the START study; Dr Meg Doherty, Coordinator of Treatment and Care in the Department of HIV/AIDS at WHO, and Giulio Maria Corbelli, Chair of the European Community Advisory Board (ECAB).

The webinar was chaired by Gus Cairns of EATG.

Avac Event

EATG Webinar 1: Treatment as Prevention

This series of three webinars, hosted jointly by EATG and AVAC, is designed to prepare and update EATG members for a special meeting on new developments in prevention on 23-25th January 2015 in Brussels.

The first webinar addressed the latest updates on treatment as prevention. Speakers included Dr. Reuben Granich, Senior Advisor for Care and Treatment at UNAIDS, Dr. Sarah Fidler of Imperial College London, and Silvia Petretti, Deputy CEO of Positively UK.

Avac Event

Pleasure, Protection, Love, Lust, And Listening to Communities: The Future of HIV Prevention is Here

A webinar in memory of HIV prevention pioneer and revolutionary Jeff McConnell. A respected and passionate sociologist, Jeff (who passed away at the age of 49 this past February) was also a gay man living with HIV, and his identity was an important component of the science he conducted. His brilliant, human-touch research on gay men’s sex, sexuality, and various prevention methodologies involving treatment and PrEP was groundbreaking, visionary, and way ahead of most of us.

Influential on a global scale, Jeff’s work has given us powerful insight into social and sexual networks – and love and pleasure – as important, necessary components of HIV prevention efforts. Panelists paid tribute and memorialized Jeff by reminding us of his pivotal contributions to science and sharing anecdotes.

They also discussed where we are today and the future of HIV prevention.

Watch the full flash webinar here.

Avac Event

UNAIDS, Targets and Civil Society

In Melbourne, UNAIDS launched a new initiative known as “90-90-90”, which lays out new targets for testing, treatment and virologic suppression. Where did these targets come from, what do they mean—and where does prevention fit in? Chris Collins, Chief of the Community Mobilization Division at UNAIDS addressed these questions and more.

Avac Event

Treatment as Prevention: Evidence from Europe and beyond

This was the third webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC. We were joined by an expert panel discussing treatment as prevention, who took questions following their presentations. To view the full Flash animation of the webinar, click here.

Avac Event

Treatment as Prevention Perspectives in Europe: An update

Hosted jointly by NAM and AVAC, the last webinar for 2013 in our series addressed a range of topics in HIV prevention research, including the development of the EATG/NAM community consensus statement on treatment as prevention, a set of principles intended to guide policy on access to antiretroviral therapy for prevention purposes for people with HIV, to be launched in January.

To view the full Flash animation of the webinar, click here.

Avac Event

US Conference on AIDS

Thousands of community leaders, front-line workers, policy makers, physicians and advocates from throughout the US met for the United States Conference on AIDS (USCA). What follows is a short list of biomedical HIV prevention research and implementation-related sessions and links to the Black Treatment Action Network/PxROAR Advocates’ Roadmap and full conference program. (The Black Treatment Action Network is a project of the Black AIDS Institute.)

The BTAN/PxROAR Advocates’ Roadmap highlights workshops, seminars and roundtables on a range of issues such as HIV prevention advocacy, access to treatment, linkage to care and the treatment cascade. Advocates who attend Roadmap sessions at the conference are eligible for prizes. Click here for more information.

Sessions of interest for biomedical HIV prevention advocates included:

Saturday, September 7